• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3-[二茂铁基(羟基)甲基]-1-甲基-2'-氧代螺[吡咯烷-2,3'-吲哚啉]-3-羧酸甲酯

Methyl 3-[ferrocen-yl(hydr-oxy)meth-yl]-1-methyl-2'-oxospiro-[pyrrolidine-2,3'-indoline]-3-carboxyl-ate.

作者信息

Kamala E Theboral Sugi, Nirmala S, Sudha L, Kathiravan S, Raghunathan R

出版信息

Acta Crystallogr Sect E Struct Rep Online. 2009 Apr 18;65(Pt 5):m531-2. doi: 10.1107/S1600536809012756.

DOI:10.1107/S1600536809012756
PMID:21583772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2977586/
Abstract

In the title compound, [Fe(C(5)H(5))(C(20)H(21)N(2)O(4))], the pyrrolidine ring exhibits an envelope conformation with the spiro-C atom deviating from the plane of the remaining four atoms. The pyrrolidine ring is almost perpendicular to the indolinone ring [dihedral angle = 87.52 (7)°]. The structure is stabilized by an intra-molecular O-H⋯N hydrogen bond and by inter-molecular C-H⋯O and N-H⋯O inter-actions.

摘要

在标题化合物[Fe(C₅H₅)(C₂₀H₂₁N₂O₄)]中,吡咯烷环呈信封式构象,螺碳原子偏离其余四个原子所在平面。吡咯烷环与吲哚酮环几乎垂直[二面角 = 87.52 (7)°]。该结构通过分子内O—H⋯N氢键以及分子间C—H⋯O和N—H⋯O相互作用得以稳定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a37/2977586/b4a181a710fd/e-65-0m531-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a37/2977586/23b9cc6aea23/e-65-0m531-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a37/2977586/b4a181a710fd/e-65-0m531-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a37/2977586/23b9cc6aea23/e-65-0m531-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a37/2977586/b4a181a710fd/e-65-0m531-fig2.jpg

相似文献

1
Methyl 3-[ferrocen-yl(hydr-oxy)meth-yl]-1-methyl-2'-oxospiro-[pyrrolidine-2,3'-indoline]-3-carboxyl-ate.3-[二茂铁基(羟基)甲基]-1-甲基-2'-氧代螺[吡咯烷-2,3'-吲哚啉]-3-羧酸甲酯
Acta Crystallogr Sect E Struct Rep Online. 2009 Apr 18;65(Pt 5):m531-2. doi: 10.1107/S1600536809012756.
2
Methyl 4'-(4-fluoro-phen-yl)-1'-methyl-3'-nitro-methyl-2-oxospiro-[indoline-3,2'-pyrrolidine]-3'-carboxyl-ate.4'-(4-氟苯基)-1'-甲基-3'-硝基亚甲基-2-氧代螺[吲哚啉-3,2'-吡咯烷]-3'-羧酸甲酯
Acta Crystallogr Sect E Struct Rep Online. 2013 Feb 1;69(Pt 2):o278. doi: 10.1107/S1600536813001578. Epub 2013 Jan 23.
3
Methyl 3'-benzyl-4'-(2-chloro-phen-yl)-1'-methyl-2-oxo-spiro-[indoline-3,2'-pyrrolidine]-3'-carboxyl-ate.3'-苄基-4'-(2-氯苯基)-1'-甲基-2-氧代-螺[吲哚啉-3,2'-吡咯烷]-3'-羧酸甲酯
Acta Crystallogr Sect E Struct Rep Online. 2013 Jul 6;69(Pt 8):o1214. doi: 10.1107/S1600536813018424. eCollection 2013.
4
Methyl 1-ethyl-3'-[hy-droxy(naphthalen-1-yl)meth-yl]-1'-methyl-2-oxo-spiro-[indo-line-3,2'-pyrrolidine]-3'-carboxyl-ate.1-乙基-3'-[羟基(萘-1-基)甲基]-1'-甲基-2-氧代-螺[吲哚啉-3,2'-吡咯烷]-3'-羧酸甲酯
Acta Crystallogr Sect E Struct Rep Online. 2014 Apr 12;70(Pt 5):o540. doi: 10.1107/S1600536814007065. eCollection 2014 May 1.
5
Methyl 5-ferrocenyl-5a-hydr-oxy-1-methyl-10-oxo-2,3,3a,4,5a,10-hexa-hydro-1H-indeno[1,2:2',3']furo[3',4'-b]pyrrole-3a-carboxyl-ate.5-二茂铁基-5a-羟基-1-甲基-10-氧代-2,3,3a,4,5a,10-六氢-1H-茚并[1,2:2',3']呋喃并[3',4'-b]吡咯-3a-羧酸甲酯
Acta Crystallogr Sect E Struct Rep Online. 2009 May 29;65(Pt 6):m687-8. doi: 10.1107/S1600536809018583.
6
Methyl 11-hy-droxy-9-[1-(4-meth-oxy-phen-yl)-4-oxo-3-phen-oxy-azetidin-2-yl]-18-oxo-10-oxa-2-aza-penta-cyclo-[9.7.0.0(1,8).0(2,6).0(12,17)]octa-deca-12(17),13,15-triene-8-carboxyl-ate.11-羟基-9-[1-(4-甲氧基苯基)-4-氧代-3-苯氧基氮杂环丁烷-2-基]-18-氧代-10-氧杂-2-氮杂五环-[9.7.0.0(1,8).0(2,6).0(12,17)]十八碳-12(17),13,15-三烯-8-羧酸甲酯
Acta Crystallogr Sect E Struct Rep Online. 2012 Jul 1;68(Pt 7):o2200-1. doi: 10.1107/S1600536812027341. Epub 2012 Jun 23.
7
4-Hydr-oxy-3-(1'-methyl-2-oxo-4'-phenyl-spiro-[indoline-3,2'-pyrrolidine]-3'-yl-carbon-yl)quinolin-2(1H)-one.4-羟基-3-(1'-甲基-2-氧代-4'-苯基-螺[吲哚啉-3,2'-吡咯烷]-3'-基-羰基)喹啉-2(1H)-酮
Acta Crystallogr Sect E Struct Rep Online. 2010 Mar 27;66(Pt 4):o952. doi: 10.1107/S1600536810010500.
8
3'-[Hy-droxy(4-oxo-4H-chromen-3-yl)meth-yl]-2-oxospiro-[indoline-3,2'-pyrrolidine]-3'-carbonitrile.3'-[羟基(4-氧代-4H-色烯-3-基)甲基]-2-氧代螺[吲哚啉-3,2'-吡咯烷]-3'-甲腈
Acta Crystallogr Sect E Struct Rep Online. 2012 Jan;68(Pt 1):o136-7. doi: 10.1107/S1600536811053098. Epub 2011 Dec 17.
9
Methyl 5''-chloro-1',1''-dimethyl-2,2''-dioxodi-spiro-[indoline-3,2'-pyrrolidine-3',3''-indoline]-4'-carboxyl-ate.5''-氯-1',1''-二甲基-2,2''-二氧代二螺-[吲哚啉-3,2'-吡咯烷-3',3''-吲哚啉]-4'-羧酸甲酯
Acta Crystallogr Sect E Struct Rep Online. 2013 May 4;69(Pt 6):o825-6. doi: 10.1107/S1600536813011501. Print 2013 Jun 1.
10
Crystal structure of methyl 3'-benzamido-4'-(4-meth-oxy-phen-yl)-1'-methyl-spiro-[indeno-[1,2-]quinoxaline-11,2'-pyrrolidine]-3'-carboxyl-ate.
Acta Crystallogr E Crystallogr Commun. 2016 Aug 5;72(Pt 9):1257-1259. doi: 10.1107/S2056989016012469. eCollection 2016 Sep 1.

本文引用的文献

1
Structure validation in chemical crystallography.化学晶体学中的结构验证
Acta Crystallogr D Biol Crystallogr. 2009 Feb;65(Pt 2):148-55. doi: 10.1107/S090744490804362X. Epub 2009 Jan 20.
2
A short history of SHELX.SHELX简史。
Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22. doi: 10.1107/S0108767307043930. Epub 2007 Dec 21.
3
Pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors. Synthesis and SAR of 2-substituted 4-methyl-8-(morpholine-4-sulfonyl)-pyrrolo[3,4-c]quinoline-1,3-diones.吡咯并[3,4-c]喹啉-1,3-二酮作为有效的半胱天冬酶-3抑制剂。2-取代-4-甲基-8-(吗啉-4-磺酰基)-吡咯并[3,4-c]喹啉-1,3-二酮的合成与构效关系
Eur J Med Chem. 2005 Dec;40(12):1377-83. doi: 10.1016/j.ejmech.2005.07.011. Epub 2005 Sep 15.
4
An empirical correction for absorption anisotropy.吸收各向异性的经验校正
Acta Crystallogr A. 1995 Jan 1;51 ( Pt 1):33-8. doi: 10.1107/s0108767394005726.
5
Isatin: identity with the purified endogenous monoamine oxidase inhibitor tribulin.异吲哚酮:与纯化的内源性单胺氧化酶抑制剂刺蒺藜素一致。
J Neurochem. 1988 Aug;51(2):656-9. doi: 10.1111/j.1471-4159.1988.tb01089.x.
6
Stress causes an increase in endogenous monoamine oxidase inhibitor (tribulin) in rat brain.压力会导致大鼠大脑中内源性单胺氧化酶抑制剂(曲布ulin)增加。 (注:原文中“tribulin”可能有误,未找到准确对应词,暂且保留原文形式翻译)
Neurosci Lett. 1988 Oct 5;92(2):218-21. doi: 10.1016/0304-3940(88)90064-x.